Perrigo Co. Plc (PRGO)

53.90
NYSE : Health Technology
Prev Close 54.39
Day Low/High 53.26 / 54.43
52 Wk Low/High 36.28 / 75.42
Avg Volume 1.22M
Exchange NYSE
Shares Outstanding 136.06M
Market Cap 7.40B
EPS 0.90
P/E Ratio 83.68
Div & Yield 0.84 (1.49%)
U.S. Stocks Open Lower as Personal Income and Spending Climb

U.S. Stocks Open Lower as Personal Income and Spending Climb

U.S. stocks opened lower Friday as personal income and spending both rose in July.

China Shares Jump in Last Hour of Trading, Dow Has Wild Ride

China Shares Jump in Last Hour of Trading, Dow Has Wild Ride

Chinese stocks jump again with the late rally that sent the Shanghai Composite Index up 5%.

RBC's 25 'Darling' Stocks to Buy After Market Pullback

RBC's 25 'Darling' Stocks to Buy After Market Pullback

Which stocks are presenting opportunities to buy? RBC Capital came up with a list of 25 stocks.

Put Impax, Akorn and Sagent on Your Watch List of Generics Targets

Put Impax, Akorn and Sagent on Your Watch List of Generics Targets

If companies such as Teva and Perrigo continue to seek growth through acquisitions, they may gobble up Impax Laboratories, Akorn Pharmaceuticals or Sagent Pharmaceuticals.

3 Stocks Pushing The Health Care Sector Lower

3 Stocks Pushing The Health Care Sector Lower

TheStreet highlights 3 stocks pushing the health care sector lower today.

3 Drugs Stocks Pushing Industry Growth

3 Drugs Stocks Pushing Industry Growth

TheStreet highlights 3 stocks pushing the drugs industry higher today.

3 Drugs Stocks Dragging The Industry Down

3 Drugs Stocks Dragging The Industry Down

TheStreet highlights 3 stocks pushing the drugs industry lower today.

Is the U.S. Bull Market Starting to Lose Its Luster?

Is the U.S. Bull Market Starting to Lose Its Luster?

CNBC’s ‘Fast Money’ traders take a closer look at U.S. stocks, as the selloff in China weighs on the market.

Perrigo (PRGO) Leads The Pack In Pre-Market Activity

Perrigo (PRGO) Leads The Pack In Pre-Market Activity

Trade-Ideas LLC identified Perrigo (PRGO) as a pre-market leader candidate

3 Stocks Pushing The Drugs Industry Higher

3 Stocks Pushing The Drugs Industry Higher

TheStreet highlights 3 stocks pushing the health services industry higher today.

Mergers and Acquisitions Boom Will Keep Rolling as Interest Rates Rise

Mergers and Acquisitions Boom Will Keep Rolling as Interest Rates Rise

The first half of 2015 saw a raft of M&A deals, and according to Chris Pultz, portfolio manager for the Kellner Merger Fund, rising rates won't slow that trend down.

Rising Rates Won’t Slow Deal Flow Says Kellner Fund Manager

Rising Rates Won’t Slow Deal Flow Says Kellner Fund Manager

Deal flow has been massive in the first half of 2015 from healthcare to technology to insurance.

3 Stocks Raising The Health Care Sector Higher

3 Stocks Raising The Health Care Sector Higher

TheStreet highlights 3 stocks pushing the health care sector higher today.

Abbott Backs Mylan and Its Strategy to Buy Perrigo

Abbott Backs Mylan and Its Strategy to Buy Perrigo

Abbott's stand is a blow to Teva, which wants to buy Mylan.

The 10 Biggest U.S. M&A Deals in 2015

The 10 Biggest U.S. M&A Deals in 2015

Health care deals dominate the list of big mergers so far this year, while tech comes in second.

Aberdeen Fund Manager Sees Israeli Stocks Pushed by Strong Economy

Aberdeen Fund Manager Sees Israeli Stocks Pushed by Strong Economy

The Israeli economy is strong, growing fast and offers good value, said William Scholes, investment manager for Aberdeen Asset management.

Strong Economy Will Push Israeli Stocks Higher Says Aberdeen Fund Manager

Strong Economy Will Push Israeli Stocks Higher Says Aberdeen Fund Manager

The Israeli economy is strong, growing fast and offers good value, according to William Scholes, investment manager for Aberdeen Asset management.

Perrigo Buys GlaxoSmithKline, Novartis Consumer Medicines

Perrigo Buys GlaxoSmithKline, Novartis Consumer Medicines

Perrigo's buy helps a joint venture between GlaxoSmithKline and Novartis that needed to cut 10 products for European approval.

Drugs Stocks On The Rise With Help From 3 Stocks

Drugs Stocks On The Rise With Help From 3 Stocks

TheStreet highlights 3 stocks pushing the drugs industry higher today.

Health Care Mergers Are Just Getting Started

Deals coming fast and furious in the best group in town.

10 S&P 500 Companies to Have the Most Revenue Growth in 2015

10 S&P 500 Companies to Have the Most Revenue Growth in 2015

The top 10 list is overwhelmingly weighted toward the health care sector, with seven companies in the biotech or pharmaceuticals industries.

Deluge of Deals Isn't About to Dry Up

Acquisitions cut into overabundance of companies.

Mylan Raises Its Offer for Generics Counterpart Perrigo

Mylan Raises Its Offer for Generics Counterpart Perrigo

Mylan announced revised terms for its unsolicited takeover offer for Perrigo, which it has rejected. This came two days after Mylan rejected a hostile bid from Teva Pharmaceuticals Industries.

Stocks Lower After Fed Signals June Hike Not Off the Table

Stocks Lower After Fed Signals June Hike Not Off the Table

Stocks pare losses mid-afternoon Wednesday after the Federal Reserve assures investors a weak first quarter was merely due to 'transitory factors.'

Stocks Curb Losses as Crude Oil Climbs on Inventory Data

Stocks Curb Losses as Crude Oil Climbs on Inventory Data

Stocks are lower on Wednesday as economic growth slows to a crawl in the first quarter.

Perrigo (PRGO) Stock Gains After Mylan Increases Takeover Bid

Perrigo (PRGO) Stock Gains After Mylan Increases Takeover Bid

Perrigo (PRGO) shares are rising after the company received its third unsolicited takeover from Mylan today with the company upping its offer to $35.6 billion.

'Green Day' Before Fed News

Market snaps back after taking early dive.

Rising Interest Rate Environment Won't Derail Merger Fund

Rising Interest Rate Environment Won't Derail Merger Fund

The Merger Fund seeks absolute returns and is not correlated to the stock market so it will fare well in a rising rate environment.

Dealmaking Frenzy Leads to Heady Days for Event-Driven Funds

Dealmaking Frenzy Leads to Heady Days for Event-Driven Funds

The surge in deal-making has created the ideal environment for merger arbitrage or event-driven funds, said K.C. Nelson, portfolio manager for the Driehaus Event Driven Fund.

S&P 500, Nasdaq Notch New Records as Amazon, Microsoft Jump

S&P 500, Nasdaq Notch New Records as Amazon, Microsoft Jump

The S&P 500 and the Nasdaq close the week at all-time highs thanks to an earnings-driven rally.

TheStreet Quant Rating: C- (Hold)